BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Institute for Bioengineering of Catalonia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ibecbarcelona.eu
X-WR-CALDESC:Events for Institute for Bioengineering of Catalonia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20210205T100000
DTEND;TZID=Europe/Madrid:20210205T120000
DTSTAMP:20260426T133424
CREATED:20210107T101425Z
LAST-MODIFIED:20210203T120455Z
UID:80728-1612519200-1612526400@ibecbarcelona.eu
SUMMARY:Online IBEC Seminar: Jordi Alcaraz
DESCRIPTION:Improving lung cancer management by reengineering tumor-associated fibroblasts\nJordi Alcaraz\, UB facultat de Medicina & IBEC Associated Researcher \nLung cancer is the leading cause of cancer death due in part to subtoptimal patient responses to current therapies\, which have been largely designed to targeting cancer cell abnormalities. However\, there is a paradigm shift in cancer research that considers tumors as abnormal organs\, thereby acknowledging the key contribution to tumor progression provided by fibroblasts and other non-cancerous stromal cells that shape the tumor mechanical and biochemical ecosystem. \nOur group pioneered the study of tumor-associated fibroblasts (TAFs) in lung cancer in Spain in collaboration with oncologists at the Hospital Clínic. I will provide an overview of our efforts in unveiling how TAFs contribute to tumor progression in major lung cancer subtypes and in identifying how can we target such contributions with new therapeutic strategies\, including the development of novel preclinical models. Moreover\, I will describe our efforts to define novel TAF-related prognostic and/or diagnostic biomarkers. Part of this work is carried out in collaboration with pharmaceutical companies. I will also briefly summarize ongoing collaborations with IBEC groups in these topics. \nThis seminar will take place online at the GoToMeeting platform \nKnow more about Jordi Alcaraz’s research here
URL:https://ibecbarcelona.eu/event/online-ibec-seminar-jordi-alcaraz/
CATEGORIES:IBEC Seminar
END:VEVENT
END:VCALENDAR